Latest Chemical pathology Stories
LONDON, March 30, 2015 /PRNewswire/ -- REPORT HIGHLIGHTSThe in vitro diagnostic renal biomarker market was valued at $771 million in 2013 and $812 million in 2014.
Study Using Caris Molecular Intelligence's Multiplatform Profiling Service Highlighted in Plenary Session at Society of Surgical Oncology Symposium IRVING, Texas, March 27, 2015 /PRNewswire/
BETHESDA, Md., March 26, 2015 /PRNewswire/ -- Precision for Medicine (www.precisionformedicine.com) today announced
Patented blood test to be used in clinical trials and as a companion diagnostic for Can-Fite's Drugs PETACH TIKVA, Israel, March 18, 2015 /PRNewswire/ --
LONDON, March 16, 2015 /PRNewswire/ -- Until superior therapeutic treatments are developed to prevent, treat and cure cancer, the best means of reducing mortality and morbidity in a disease
Studies Examine Use of Biomarkers in Patients with Risk Factors for Acute Kidney Injury SAN DIEGO, March 16, 2015 /PRNewswire/ -- Astute Medical, Inc., developer of the NEPHROCHECK(®) Test,
HAYWARD, California, March 9, 2015 /PRNewswire/ -- Advanced Cell Diagnostics, Inc. (ACD) announced today that Merrimack Pharmaceuticals, Inc.
FORT WORTH, Texas, March 6, 2015 /PRNewswire/ -- The increasing demand for petroleum, petrochemical, fine & specialty chemicals natural gas, and industrial gas globally
FORT WORTH, Texas, March 2, 2015 /PRNewswire/ -- The global pre-packed columns report defines and segments the concerned market with an analysis and forecast of revenue.
- Large; stout; burly.